Literature DB >> 19525085

Improved diagnosis and treatment of soft tissue sarcoma patients after implementation of national guidelines: a population-based study.

M L E A Jansen-Landheer1, P Krijnen, M J Oostindiër, W M Kloosterman-Boele, E M Noordijk, M A Nooij, W H Steup, A H M Taminiau, R Vree, P C W Hogendoorn, R A E M Tollenaar, H Gelderblom.   

Abstract

AIM: The majority of clinicians, radiologists and pathologists have limited experience with soft tissue sarcomas. In 2004, national guidelines were established in The Netherlands to improve the quality of diagnosis and treatment of these rare tumours. This study evaluates the compliance with the guidelines over time. PATIENTS: Population-based series of 119 operated patients with a soft tissue sarcoma (STS) diagnosed in 1998-1999 (79 before implementation of new guidelines) and in 2006 (40 after implementation).
METHODS: Coded information regarding patient and tumour characteristics as well as (the results of) pathology review was collected from the medical patient file by two experienced data-managers.
RESULTS: Diagnostic imaging of the tumour was performed according to the guidelines in 75-100% depending on the site of the tumour (abdominal versus non-abdominal) as well as the time of diagnosis. Adherence to the guidelines with respect to invasive diagnostic procedures in patients with non-abdominal STS improved over time. A pre-operative histological diagnosis was obtained in 42% of the patients in 1998-1999 and in 72% of the patients in 2006 (p<0.001). The guidelines for reporting on pathology were increasingly adhered to. In 2006, (nearly) all pathology reports mentioned tumour size, morphology, tumour grade, resection margins and radicality. This represents a major improvement compared to the pathology reports in 1998-1999, where these aspects were not mentioned in 14-40% of the cases. The proportion of prospective pathology reviews by (a member of) the expert panel increased from 60% in 1998-1999 to 90% in 2006 (p=0.001). DISCUSSION: The compliance with the guidelines has been optimised by the increased attention to this group of patients. Most important factors have been the reporting of the results of the first evaluation and (discussions about) the centralisation of treatment. Further improvements could be reached by the prospective web based registry monitoring logistic aspects as well as parameters useful for the evaluation of the quality of care.

Entities:  

Mesh:

Year:  2009        PMID: 19525085     DOI: 10.1016/j.ejso.2009.05.002

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  16 in total

1.  Conformity to Clinical Practice Guidelines at Initial Management in Adult Soft Tissue and Visceral Tumors since the Implementation of the NetSarc Network in Eastern France.

Authors:  Justine Gantzer; Antonio Di Marco; Thibaut Fabacher; Noelle Weingertner; Jean-Baptiste Delhorme; David Brinkert; Guillaume Bierry; Jean-Pierre Ghnassia; Jérémie Jégu; Jean-Emmanuel Kurtz
Journal:  Oncologist       Date:  2019-05-09

2.  Comparison between MRI with spin-echo echo-planar diffusion-weighted sequence (DWI) and histology in the diagnosis of soft-tissue tumours.

Authors:  E Genovese; A Canì; S Rizzo; M G Angeretti; A Leonardi; C Fugazzola
Journal:  Radiol Med       Date:  2011-03-19       Impact factor: 3.469

3.  Adherence to consensus-based diagnosis and treatment guidelines in adult soft-tissue sarcoma patients: a French prospective population-based study.

Authors:  S Mathoulin-Pélissier; C Chevreau; C Bellera; E Bauvin; M Savès; P Grosclaude; S Albert; J Goddard; S Le Guellec; M Delannes; B N Bui; J Mendiboure; E Stoeckle; J M Coindre; G Kantor; M Kind; A Cowppli-Bony; S Hoppe; A Italiano
Journal:  Ann Oncol       Date:  2013-11-26       Impact factor: 32.976

4.  Moving Forward Through Consensus: A Modified Delphi Approach to Determine the Top Research Priorities in Orthopaedic Oncology.

Authors:  Patricia Jacqueline Schneider; Nathan Evaniew; Paula McKay; Michelle Ghert
Journal:  Clin Orthop Relat Res       Date:  2017-08-30       Impact factor: 4.176

5.  Adequacy of pathology reports of specimens from patients with differentiated thyroid cancer.

Authors:  Ma Luisa Isidro; Gloria Lugo; Olga Fidalgo; Sara García-Arias
Journal:  Endocr Pathol       Date:  2012-12       Impact factor: 3.943

6.  Multimodality management of extremity soft tissue sarcomas-an Indian perspective.

Authors:  Ajay Puri; Ashish Gulia
Journal:  Indian J Surg Oncol       Date:  2012-01-31

7.  Territorial inequalities in management and conformity to clinical guidelines for sarcoma patients: an exhaustive population-based cohort analysis in the Rhône-Alpes region.

Authors:  Pierre Etienne Heudel; Philippe Cousin; Antoine Lurkin; Claire Cropet; Françoise Ducimetiere; Olivier Collard; Guy De Laroche; Pierre Biron; Pierre Meeus; Philippe Thiesse; Christophe Bergeron; Gualter Vaz; François Mithieux; Fadila Farsi; Yohan Fayet; François-Noel Gilly; Dominic Cellier; Jean-Yves Blay; Isabelle Ray-Coquard
Journal:  Int J Clin Oncol       Date:  2013-08-10       Impact factor: 3.402

8.  Management of extremity soft tissue sarcomas.

Authors:  Ajay Puri; Ashish Gulia
Journal:  Indian J Orthop       Date:  2011-07       Impact factor: 1.251

9.  Clinicians' adherence versus non adherence to practice guidelines in the management of patients with sarcoma: a cost-effectiveness assessment in two European regions.

Authors:  Lionel Perrier; Alessandra Buja; Giuseppe Mastrangelo; Antonella Vecchiato; Paolo Sandonà; Françoise Ducimetière; Jean-Yves Blay; François Noël Gilly; Carole Siani; Pierre Biron; Dominique Ranchère-Vince; Anne-Valérie Decouvelaere; Philippe Thiesse; Christophe Bergeron; Angelo Paolo Dei Tos; Jean-Michel Coindre; Carlo Riccardo Rossi; Isabelle Ray-Coquard
Journal:  BMC Health Serv Res       Date:  2012-03-28       Impact factor: 2.655

10.  Improvement of the initial management of sarcomas after the dissemination of evidence-based guidelines depends on the primary sarcoma location: a population-based study.

Authors:  Karine Ligier; Carlos Maynou; Xavier Leroy; Yves-Marie Robin; Philippe Martin; Stéphanie Clisant; Florence Richard; Nicolas Penel
Journal:  BMC Cancer       Date:  2015-04-02       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.